shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > Lifestyle News > Health And Fitness News > Article > Stopped manufacturing supply of additional Covishield doses disclosed all side effects Serum Institute

Stopped manufacturing, supply of additional Covishield doses, disclosed all side effects: Serum Institute

Updated on: 08 May,2024 06:27 PM IST  |  Mumbai
IANS |

The revelation comes amid British-Swedish pharma giant AstraZeneca recalling its Covid-19 vaccine globally after it acknowledged in late April that the vaccine can cause thrombosis as a side-effect

Stopped manufacturing, supply of additional Covishield doses, disclosed all side effects: Serum Institute

The SII stressed that despite the challenges faced during the global pandemic, the safety of the vaccine remains paramount. Photo Courtesy: AFP

As British-Swedish pharma giant AstraZeneca recalled its Covid-19 vaccine globally, Pune-based Serum Institute of India (SII) on Wednesday said it stopped the manufacturing and supply of additional doses of Covishield in December 2021.


AstraZeneca has voluntarily withdrawn the "marketing authorisation" of its Covid vaccine, sold as Covishield in India and Vaxzevria in Europe.


In a statement to IANS, an SII spokesperson said that with India achieving high vaccination rates in 2021 and 2022, coupled with the emergence of new mutant variant strains, the demand for previous vaccines diminished significantly.


"Consequently, since December 2021, we have stopped the manufacturing and supply of additional doses of Covishield," the spokesperson added.

The Serum Institute said that they fully understand the ongoing concerns and "it's crucial to emphasise our commitment to transparency and safety".

The company said that from the outset, "we have disclosed all rare to very rare side effects, including Thrombosis with Thrombocytopenia Syndrome, in the packaging insert in 2021".

Thrombotic Thrombocytopenic Syndrome (TTS) is a rare side effect that can cause people to have blood clots and a low blood platelet count, linked to at least 81 deaths in the UK as well as hundreds of serious injuries.

The SII stressed that despite the challenges faced during the global pandemic, the safety of the vaccine remains paramount.

"Regardless of whether it's AstraZeneca's Vaxzervria or our own Covishield, both vaccines have been instrumental in saving millions of lives worldwide.

"We commend the collaborative efforts of governments and ministries in facilitating a unified global response to the pandemic," added the Serum Institute.

Meanwhile, the British-Swedish multinational pharmaceutical is also being sued by more than 50 alleged victims and grieving relatives in a High Court case in the UK.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK